Active Ingredient: POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC
Proprietary Name: POTASSIUM PHOSPHATES
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N212121
Product Number: 001
Approval Date: Sep 19, 2019
Applicant Holder Full Name: CMP DEVELOPMENT LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
